DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. $(GILD)$ shed 2.21% to $103.19 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.57% to 4,982.77 and Dow Jones Industrial Average falling 0.84% to 37,645.59.
This was the stock's third consecutive day of losses.
Gilead Sciences Inc. closed 13.98% short of its 52-week high of $119.96, which the company reached on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.41% to $150.00, Pfizer Inc. $(PFE)$ fell 3.49% to $21.84, and Abbott Laboratories $(ABT)$ fell 0.73% to $123.95.
Trading volume (11.2 M) eclipsed its 50-day average volume of 9.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 08, 2025 16:37 ET (20:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。